Skip to main content
SpringerLink
Log in

Cutaneous Manifestations of Gastrointestinal Diseases

  • Chapter
  • First Online:
Atlas of Dermatology in Internal Medicine

  • 3057 Accesses

Abstract

Many gastrointestinal diseases have a variety of cutaneous manifestations that may herald the start of the disease or correlate with disease activity. The gastrointestinal diseases and its cutaneous manifestations that will be discussed in this chapter are inflammatory bowel disease (Crohn’s disease and ulcerative colitis), erythema nodosum, pyoderma ­gangrenosum, Sweet’s syndrome, nutritional and metabolic disorders (dermatitis herpetiformis), lichen planus, gastrointestinal hemorrhage (Kaposi’s sarcoma), and gastrointestinal neoplasias (necrolytic migratory erythema and Gardner’s, Müir–Torre, Peutz–Jeghers, and Bazex’s syndrome). Early recognition of the cutaneous manifestations associated with gastrointestinal diseases or neoplasia will lead to prompt referral of the patient (and relatives if indicated) for ­gastroenterological evaluation and successful prevention, diagnosis, or therapy of these illnesses. This, in turn, may guide to early intervention, management, and decrease the progression to advanced disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McQuaid KR. Alimentary tract. In: Tierney LM, McPhee SJ, Papadakis MA, editors. Lange current medical diagnosis & treatment. 43rd ed. New York: McGraw-Hill; 2004. p. 515–622.

    Google Scholar 

  2. Boh EE, al-Smadi RM. Cutaneous manifestations of gastrointestinal diseases. Dermatol Clin. 2002;20:533–46.

    Article  PubMed  Google Scholar 

  3. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. 1998;37:667–72.

    Article  PubMed  CAS  Google Scholar 

  4. Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000;43:584–92.

    Article  PubMed  CAS  Google Scholar 

  5. Mert A, Ozaras R, Tabak F, et al. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36:424–7.

    Article  PubMed  Google Scholar 

  6. Berger TG. Skin, hair, & nails. In: Tierney LM, McPhee SJ, Papadakis MA, editors. Lange current medical diagnosis & treatment. 43rd ed. New York: McGraw-Hill; 2004. p. 81–144.

    Google Scholar 

  7. Yotsu R, Mii S, Hayashi R, Harada H, Furukawa K, Eto H. Erythema nodosum associated with Yersinia enterocolitica infection. J Dermatol. 2010;37(9):819–22.

    Article  PubMed  Google Scholar 

  8. Senturk T, Aydintug O, Kuzu I, et al. Adhesion molecule expression in erythema nodosum-like lesions in Behcet’s disease. A histopathological and immunohistochemical study. Rheumatol Int. 1998;18:51–7.

    Article  PubMed  CAS  Google Scholar 

  9. Hanauer SB. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum? Inflamm Bowel Dis. 1998;4:70. discussion 73.

    Article  PubMed  CAS  Google Scholar 

  10. Horio T, Imamura S, Danno K, Ofuji S. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol. 1981;117:29–31.

    Article  PubMed  CAS  Google Scholar 

  11. Marshall JK, Irvine EJ. Successful therapy of refractory erythema nodosum associated with Crohn’s disease using potassium iodide. Can J Gastroenterol. 1997;11:501–2.

    PubMed  CAS  Google Scholar 

  12. Vavricka SR et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1):110–9.

    Article  PubMed  Google Scholar 

  13. Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol. 1988;19:983–1005.

    Article  PubMed  CAS  Google Scholar 

  14. Huang W, McNeely MC. Neutrophilic tissue reactions. Adv Dermatol. 1997;13:33–64.

    PubMed  CAS  Google Scholar 

  15. Fox LP, Geyer AS, Husain S, Grossman ME. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia. Leuk Lymphoma. 2006;47:147–50.

    Article  PubMed  Google Scholar 

  16. Wiseman DH, Hunter HJ, Dennis M. Bullous pyoderma gangrenosum in acute myeloid leukaemia. Eur J Haematol. 2007;79:91–2.

    Article  PubMed  Google Scholar 

  17. Shankar S, Sterling JC, Rytina E. Pustular pyoderma gangrenosum. Clin Exp Dermatol. 2003;28:600–3.

    Article  PubMed  CAS  Google Scholar 

  18. Langan SM, Powell FC. Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature. Int J Dermatol. 2005;44:623–9.

    Article  PubMed  Google Scholar 

  19. Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol. 1993;15:28–33.

    Article  PubMed  CAS  Google Scholar 

  20. Powell FC, O’Kane M. Management of pyoderma gangrenosum. Dermatol Clin. 2002;20:347–55, viii.

    Google Scholar 

  21. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol. 2000;18:283–93.

    Article  PubMed  CAS  Google Scholar 

  22. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol. 1996;34:395–409. quiz 410–2.

    Article  PubMed  CAS  Google Scholar 

  23. Reguiai Z, Grange F. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol. 2007;8:67–77.

    Article  PubMed  Google Scholar 

  24. Regueiro M, Valentine J, Plevy S, et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003;98:1821–6.

    Article  PubMed  CAS  Google Scholar 

  25. Kirsner RS. Biological agents for chronic wounds. Am J Clin Dermatol. 2010;11 Suppl 1:23–5.

    Article  PubMed  Google Scholar 

  26. Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol. 2005;32:199–203.

    PubMed  Google Scholar 

  27. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964;76:349–56.

    Article  PubMed  CAS  Google Scholar 

  28. Whittle CH, Beck GA, Champion RH. Recurrent neutrophilic dermatosis of the face – a variant of Sweet’s syndrome. Br J Dermatol. 1968;80:806–10.

    Article  PubMed  CAS  Google Scholar 

  29. Fett DL, Gibson LE, Su WP. Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70:234–40.

    Article  PubMed  CAS  Google Scholar 

  30. Kurkcuoglu N, Aksoy F. Sweet’s syndrome associated with Helicobacter pylori infection. J Am Acad Dermatol. 1997;37:123–4.

    Article  PubMed  CAS  Google Scholar 

  31. Cohen PR, Kurzrock R. Sweet’s syndrome and malignancy. Am J Med. 1987;82:1220–6.

    Article  PubMed  CAS  Google Scholar 

  32. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol. 1988;6:1887–97.

    PubMed  CAS  Google Scholar 

  33. Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol. 1993;11:149–57.

    Article  PubMed  CAS  Google Scholar 

  34. Cohen PR, Kurzrock R. Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18:265–82.

    Article  PubMed  CAS  Google Scholar 

  35. Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761–78.

    Article  PubMed  Google Scholar 

  36. Thompson DF, Montarella KE. Drug-induced Sweet’s syndrome. Ann Pharmacother. 2007;41:802–11.

    Article  PubMed  CAS  Google Scholar 

  37. Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY. Sweet’s ­syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines? J Am Acad Dermatol. 1998;39:940–3.

    Article  PubMed  CAS  Google Scholar 

  38. Going JJ. Is the pathogenesis of Sweet’s syndrome mediated by interleukin-1? Br J Dermatol. 1987;116:282–3.

    Article  PubMed  CAS  Google Scholar 

  39. Rugo HS. Cancer. In: Tierney LM, McPhee SJ, Papadakis MA, ­editors. Lange current medical diagnosis & treatment. 43rd ed. New York: McGraw-Hill; 2004. p. 1577–635.

    Google Scholar 

  40. Tabanlioglu D, Boztepe G, Erkin G, Gokoz O, Karaduman A. Sweet’s syndrome and erythema nodosum: a companionship or a spectrum? – A case report with review of literature. Int J Dermatol. 2010;49(1):62–6.

    Article  PubMed  Google Scholar 

  41. Cohen PR, Kurzrock R. Sweet’s syndrome: a review of current treatment options. Am J Clin Dermatol. 2002;3:117–31.

    Article  PubMed  Google Scholar 

  42. Bianchi L, Masi M, Hagman JH, et al. Systemic interferon-alpha treatment for idiopathic Sweet’s syndrome. Clin Exp Dermatol. 1999;24:443–5.

    Article  PubMed  CAS  Google Scholar 

  43. Duhring LA. Landmark article, Aug 30, 1884: dermatitis herpetiformis. By Louis A. Duhring. JAMA. 1983;250:212–6.

    Article  PubMed  CAS  Google Scholar 

  44. Hall RP, Sanders ME, Duquesnoy RJ, et al. Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis. J Invest Dermatol. 1989;93:501–5.

    Article  PubMed  CAS  Google Scholar 

  45. Olbricht SM, Flotte TJ, Collins AB, et al. TJ. Dermatitis herpetiformis. Cutaneous deposition of polyclonal IgA1. Arch Dermatol. 1986;122:418–21.

    Article  PubMed  CAS  Google Scholar 

  46. Rose C, Brocker EB, Zillikens D. Clinical, histological and immunopathological findings in 32 patients with dermatitis herpetiformis. J Dtsch Dermatol Ges. 2010;8(4):265–71.

    Article  PubMed  Google Scholar 

  47. van der Meer JB. Gluten-free diet and elemental diet in dermatitis herpetiformis. Int J Dermatol. 1990;29:679–92.

    Article  PubMed  Google Scholar 

  48. Irla N, Schneiter T, Haneke E, Yawalkar N. Nail Lichen Planus: successful treatment with Etanercept. Case Rep Dermatol. 2010;2(3):173–6.

    Article  PubMed  Google Scholar 

  49. NCI. Kaposi sarcoma treatment (PDQ®): patient version: U.S. National Institutes of Health; 2007.

    Google Scholar 

  50. Potthoff A, Brockmeyer NH, Stucker M, Wieland U, Krenter A. Kaposi Sarcoma in a HIV uninfected man who has sex with men. Eur J Med Res. 2010;15(2):79–80.

    PubMed  Google Scholar 

  51. Wijn MA, Keller JJ, Giardiello FM, Brand HS. Oral and maxillofacial manifestations of familial adenomatous polyposis. Oral Dis. 2007;13:360–5.

    Article  PubMed  CAS  Google Scholar 

  52. Finan MC, Ray MK. Gastrointestinal polyposis syndromes. Dermatol Clin. 1989;7:419–34.

    PubMed  CAS  Google Scholar 

  53. Alexander AA, Patel AA, Odland R. Paranasal sinus osteomas and Gardner’s syndrome. Ann Otol Rhinol Laryngol. 2007;116:658–62.

    PubMed  Google Scholar 

  54. Chung J, Namkoong S, Jung KE, Park JW, Park BC, Cinn YW, et al. A case of Gardner’s syndrome associated with desmoid tumor. Ann Dermatol. 2010;22(4):418–21.

    Article  PubMed  Google Scholar 

  55. Nunez Nunez R, Galan Gomez E, Moreno Hurtado C, et al. [Familial adenomatous polyposis: Gardner’s syndrome]. Cir Pediatr. 2006;19:111–4.

    PubMed  CAS  Google Scholar 

  56. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year ­retrospect. J Am Acad Dermatol. 1995;33:90–104.

    Article  PubMed  CAS  Google Scholar 

  57. Lachiewicz AM, Wilkinson TM, Groben P, et al. Muir-Torre ­syndrome. Am J Clin Dermatol. 2007;8:315–9.

    Article  PubMed  Google Scholar 

  58. Lynch MC, Anderson BE. Ileocecal Adenocarcinoma and unilateral transitional cell carcinoma with multiple sebaceous tumors and keratoacanthomas in a case of Muir-Torre syndrome. Dermatol Res Pract. 2010;2010. pii:173160.

    Google Scholar 

  59. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453–6.

    Article  PubMed  CAS  Google Scholar 

  60. Morales A, Figueroa LD. Muir-Torre syndrome. Caribb J Dermatol Ther. 2006;3:33–5.

    Google Scholar 

  61. Spielvogel RL, DeVillez RL, Roberts LC. Oral isotretinoin therapy for familial Muir-Torre syndrome. J Am Acad Dermatol. 1985;12:475–80.

    Article  PubMed  CAS  Google Scholar 

  62. Graefe T, Wollina U, Schulz H, Burgdorf W. Muir-Torre ­syndrome – treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000;200:331–3.

    Article  PubMed  CAS  Google Scholar 

  63. Peutz JL. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane (Dutch). Nederl Maandschrift voor Geneeskunde. 1921;10:134–46.

    Google Scholar 

  64. Jeghers H, Mc KV, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med. 1949;241:1031–6.

    Article  PubMed  CAS  Google Scholar 

  65. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18:38–43.

    Article  PubMed  CAS  Google Scholar 

  66. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391:184–7.

    Article  PubMed  CAS  Google Scholar 

  67. Mangili G, Taccagni G, Garavaglia E, et al. An unusual admixture of neoplastic and metaplastic lesions of the female genital tract in the Peutz-Jeghers Syndrome. Gynecol Oncol. 2004;92:337–42.

    Article  PubMed  Google Scholar 

  68. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:3053–63.

    Article  PubMed  CAS  Google Scholar 

  69. Karabulut AA, Sahin S, Sahin M, et al. Paraneoplastic acrokeratosis of Bazex (Bazex’s syndrome): report of a female case associated with cholangiocarcinoma and review of the published work. J Dermatol. 2006;33:850–4.

    Article  PubMed  Google Scholar 

  70. Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore). 1991;70:269–80.

    CAS  Google Scholar 

  71. Vandersteen PR, Scheithauer BW. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study. J Am Acad Dermatol. 1985;12:1032–9.

    Article  PubMed  CAS  Google Scholar 

  72. Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part I. J Am Acad Dermatol. 1992;26:153–66.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, Puerto Rico

    María I. Vázquez-Roque & Wilfredo E. De Jesús-Monge

Authors
  1. María I. Vázquez-Roque
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilfredo E. De Jesús-Monge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to María I. Vázquez-Roque .

Editor information

Editors and Affiliations

  1. and Dermatology and chairman, Department of Dermatology, Professor of Dermatopathology, Medical Sciences Campus School of Medicine, San Juan, 00931, Puerto Rico

    Néstor P. Sánchez

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Vázquez-Roque, M.I., De Jesús-Monge, W.E. (2012). Cutaneous Manifestations of Gastrointestinal Diseases. In: Sánchez, N. (eds) Atlas of Dermatology in Internal Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0688-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0688-4_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-0687-7

  • Online ISBN: 978-1-4614-0688-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation